Netspot GA68 GLA

Ended Awarded Last action

Contract number
36C26225F0175
Awardee
Awarding agency
Obligated
$89,367

Award facts

Contract value 100% obligated
$89,366.94 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Lake Mary, FL 32746, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 -$71,035
Original award $160,402

About this award

Advanced Accelerator Applications USA Inc., a Novartis subsidiary specializing in radiopharmaceuticals and nuclear medicine products, was awarded a delivery order for NETSPOT GA68 GLA valued at $89,366.94 by Veterans Integrated Service Network 22 on January 3, 2025. The contract is structured as a firm fixed-price delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with an ultimate completion date of January 2, 2026, and will be performed at the company's distribution facility in Lake Mary, Florida. This award carries no small business set-aside designation, consistent with Advanced Accelerator Applications USA Inc.'s classification as a large specialized manufacturer. NETSPOT (gallium Ga 68 dotatate) is a diagnostic radiopharmaceutical used for positron emission tomography imaging in nuclear medicine applications, particularly for detecting certain neuroendocrine tumors and other conditions.

This delivery order is issued under one of Advanced Accelerator Applications USA Inc.'s existing blanket purchase agreements or indefinite delivery contracts with the Veterans Integrated Service Network, leveraging the established FSS-61-IB schedule vehicle to support the Department of Veterans Affairs' nuclear medicine imaging capabilities. The Department of Veterans Affairs has been the company's predominant federal customer, awarding numerous delivery orders across multiple Veterans Integrated Service Networks for specialized radiopharmaceutical products including PLUVICTO, LUTATHERA, and NETSPOT. The contractor serves as the prime supplier with no identified subcontractors, providing direct supply of these critical diagnostic and therapeutic nuclear medicine products to VA medical centers nationwide.

Quick answers

Who was awarded contract 36C26225F0175?

36C26225F0175 was awarded to Advanced Accelerator Applications USA Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on January 3, 2025.

How much is contract 36C26225F0175 worth?

The government has obligated $89,367 on 36C26225F0175.

Is contract 36C26225F0175 an order under another contract?

Yes. 36C26225F0175 is a delivery order under 36F79719D0169, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26225F0175 competed?

The extent of competition for 36C26225F0175 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award